期刊文献+

口服避孕药预处理在卵巢功能储备良好而前次IVF失败患者中的应用效果 被引量:3

Effect Analysis of Oral Contraceptive Pills for Pretreatment on Next IVF Outcome of Patients Failed Previously with Fine Ovary Reserve
原文传递
导出
摘要 目的:评估口服避孕药(OC)预处理在卵巢储备良好、前次IVF失败患者中的应用效果。方法:回顾分析131例卵巢储备功能良好、前次IVF常规黄体中期降调节长方案失败再次行助孕治疗的患者资料,其中口服避孕药预处理后长方案治疗52例为研究组,黄体中期长方案治疗79例为对照组。结果:研究组降调节后LH值明显低于对照组,双原核(2PN)率和卵裂率明显高于对照组,可利用胚胎数明显高于对照组(P<0.05);但Gn使用时间、Gn使用量、获卵数、MII卵数、移植日子宫内膜厚度、生化及临床妊娠率、因OHSS倾向取消移植率与对照组比较均无明显统计学差异(P>0.05)。结论:在有自发排卵的卵巢储备功能良好、前次IVF常规长方案失败、再次选用长方案超促排卵(COH)治疗的患者中,使用OC预处理能够降低降调节后LH值,改善正常受精率,增加可利用胚胎数,是值得推荐的治疗方案。 Objective: To evaluate the effect of oral contraceptive pills (OC) for pretreatment on the once- again IVF cycle outcome of patients with fine ovary reserve and previous failing IVF/ICSI-ET cycle. Methods: A total of 131 patients with previous failing cycle of mid-luteal phase GnRHa long protocol but with fine ovary reserve who underwent a second-time IVF were retrospectively analyzed. All cases were divided into 2 groups: OC group of 52 patients were treated with long protocol cycle after OC pretreatment, while the control included 79 patients who underwent long protocol treated with GnRHa from mid-luteal phase. Results: The LH level after down regulation in OC group was significantly lower than that in the control, while the fertilization rate, the cleavage rate and the number of utilized embryo were significantly higher than those in the control. But for the items of the number of stimulation days, total ampoules of gonadotropin (Gn), the number of oocytes retrieved, the number of Mu oocytes, thickness of endometrium on ET day, pregnancy rates and OHSS inclination caused cycle cancel rates, there were no significant differences between the two groups. Conclusion: For patients with fine ovary reserve and spontaneous ovulation who failed in previous IVF regular long protocol cycle and underwent long protocol con- trolled ovarian stimulation again, OC pretreatment can decrease LH level after down regulation, improve the fertili- zation rate and increase utilized embryo number, which proved recommendable way of treatment protocol.
出处 《生殖与避孕》 CAS CSCD 2012年第12期852-856,共5页 Reproduction and Contraception
关键词 口服避孕药(OC) 预处理 长方案 体外受精-胚胎移植(IVF-ET) 促性腺激素释放激素激动剂(GnRHa) 双原核(2PN)率 oral contraceptive (OC) pretreatment long protocol in vitro fertilization-embryo transfer (IVF- ET) gonadotropin releasing hormone agonist (GnRHa) 2PN rate
  • 相关文献

参考文献16

  • 1Porter RN, Smith W, Croft IL, et al. Induction of ovulation for in-vitro fertilization using buserelin and gonadotropins. Lancet, 1984, 2(8414):1284-5.
  • 2Dana.rio MA, Barmat L, Liu HC, et al. Dual suppression with oral contraceptives and gonadotropin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients. Hum Reprod, 1997, 12(11):2359-65.
  • 3Kovacs P, Barg PE, Witt BR. Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles. J Assist Reprod Genet, 2001, 18(7):391-4.
  • 4Bozdag G, Esinler I, Yarali H. Pretreatment with oral contraceptive pills does not influence the pregnancy rate in the long leuprolide acetate protocol. Gynecol Obstet Invest, 2012, 73(1):53-7.
  • 5Griesinger G, Venetis CA, Marx T, et al. Oral contraceptive pill retreatment in ovarian stimulation with CmRH antagonists for IVF: a systematic review and meta-analysis. Fertil Steril, 2008, 90(4): 1055-63.
  • 6Bancsi LF, Broekmans F J, Eijkemans M J, et al. Predictors of poor ovarian response in in-vitro fertilization: a prospective study com paring basal markers of ovarian reserve. Fertil Steril, 2002, 77(2):328-36.
  • 7Frattarelli JL, Lauria Costab DF, Miller BT, et al. Basal antralfollicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive techno Iogy cycles. Fertil Steril, 2000, 74(3):512-7.
  • 8Kolibianakis EM, Papanikolaou EG, Camus M, et al. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod, 2006, 21(2):352-7.
  • 9Keltz MD, Gera PS, Skorupski J, et al. Comparison of FSH flare with and without pretreatment with oral contraceptive pills in poor responders undergoing in vitro fertilization. Fertil Steril, 2007, 88(2):350-3.
  • 10朱桂金,聂睿,徐蓓.卵泡刺激素和黄体生成素阈值与阈值窗及卵泡的发育[J].生殖医学杂志,2008,17(6):401-404. 被引量:14

二级参考文献22

  • 1Schoemaker J, van weissenbruch MM, Scheele F,et al. The FSH threshold concept in clinical ovulation induction [J]. Baill Clin Obstet Gyneeot, 1993,7(2):297-308.
  • 2Sehipper I, Hop WC, Fauser BC. The follicle-stimulating hormone(FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development[J]. J Clin Endocrinol Metab, 1998,83 (4) : 1292-1298.
  • 3de koxing CH, Schoemaker J, Lambalk CB. Estimation of the follicle-stimulating hormone threshold for initiating the final stages of follicular development in women with elevated FSH level in the early follicular phase [J]. Fertil Steril, 2004,82(3) :650-653.
  • 4van Der meer M, Cohort size rather than follicle stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndromeFJ3. J Clin Endocrinol Metab, 1998,83 (2) : 423-426.
  • 5Palermo R. Differential actions of FSH and LH during folticulogenesis[J]. Reprod Biomed Online, 2007,15 (3): 326-337.
  • 6Balasch J, Faregues F. LH in the follicular phase: neither too high nor too low[J]. Reprod Biomed Online, 2006, 12 (4) :406-415.
  • 7Macklon NS, Fauser BC. Follicle-stimulation hormone and advanced follicle development in the human[J]. Archives of Med Res, 2001,32(6) :595-600.
  • 8Mersereau JE, Evans ML, Moore DH, et al. Luteal phase estrogen is decreased in regularly menstruating older women compared with a reference population of younger women[J]. Menopause, 2008,15 (5) : 482-486.
  • 9Borini A, Dal Prato L. Tailoring FSH and LH administration to individual patients[J]. Reprod Biomed Online, 2005, 11 (3) :283-293.
  • 10Ziegler D. Roles of FSH and LH during the follicular phase: insight into natural cycle IVF[J]. Reprod Biomed Online, 2007,15(5) : 507-513.

共引文献23

同被引文献54

  • 1李力,乔杰.实用生殖医学.北京:人民卫生出版,2012:358-359.
  • 2Sobotka V,Streda R, Mardesic T, et al. Steroids pretreatmentin assisted reproduction cycles. J Steroid Biochem Mol Biol,2014,139:114-21.
  • 3Frydman R, Forman R, Rainhom JD, et al. A new approachto follicular stimulation for in vitro fertilization: programedoocyte retrieval. Fertil Steril,1986,46(4):657-62.
  • 4Deb S, Raine F. Role of combined oral contraceptives inwomen undergoing assisted reproduction treatment. Ex-pert Rev Obstet Gynecol, 2011,6(5):495-9.
  • 5Smulders B, van Oirschot SM, Farquhar C, et al. Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database SystRev, 2010, 20(1):CD006109.
  • 6Griesinger G, Kolibianakis EM,Venetis C, et al. Oral contra-ceptive pretreatment significantly reduces ongoing pregnancylikelihood in gonadotropin-releasing hormone antagonistcycles: an updated meta-analysis. Fertil Steril, 2010, 94(6):2382-4.
  • 7Kolibianakis EM, Venetis CA, Tarlatzis BC. The effect of oralcontraceptives on assisted reproductive technology correctedcycles. Curr Opin Obstet Gynecol, 2007,19(3):244-7.
  • 8Grimes DA, Jones LB, Lopez LM, et al. Oral contraceptivesfor functional ovarian cysts. Cochrane Database Syst Rev,2014,4:CD006134.
  • 9Humaidan PQ, Papanikolaou EG. Preventing ovarian hyper-stimulation syndrome: guidance for the clinician. Fertil Steril,2010, 94(2):389-400.
  • 10Oudendijk JF, Yarde F,Eijkemans MJ, et al. The poorresponder in IVF: is the prognosis always poor? A system-atic review. Hum Reprod Update, 2012,18(1):1-11.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部